Stock Track | DaVita HealthCare Partners Soars 7.10% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance

Stock Track

May 06

DaVita HealthCare Partners' stock surged 7.10% in pre-market trading on Wednesday, following the release of its first-quarter financial results for fiscal year 2026.

The significant pre-market gain was driven by the company reporting quarterly adjusted earnings that significantly exceeded Wall Street expectations. DaVita posted adjusted earnings per share of $2.87 for the quarter ended March 31, beating the analyst consensus estimate of $2.32. Revenue for the quarter climbed to $3.42 billion, also surpassing the market expectation of $3.36 billion.

Furthermore, DaVita raised its full-year 2026 adjusted earnings per share guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00. The company cited strong and steady demand for its kidney dialysis services and operational execution as key drivers for the improved financial performance and outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1174231010"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1174231010\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1174231010?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 16:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174231010","market":"sg","top_or_hot":-1,"title":"Stock Track | DaVita HealthCare Partners Soars 7.10% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance","media":"Stock Track","content":"<p>DaVita HealthCare Partners' stock surged 7.10% in pre-market trading on Wednesday, following the release of its first-quarter financial results for fiscal year 2026.</p><p>The significant pre-market gain was driven by the company reporting quarterly adjusted earnings that significantly exceeded Wall Street expectations. DaVita posted adjusted earnings per share of $2.87 for the quarter ended March 31, beating the analyst consensus estimate of $2.32. Revenue for the quarter climbed to $3.42 billion, also surpassing the market expectation of $3.36 billion.</p><p>Furthermore, DaVita raised its full-year 2026 adjusted earnings per share guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00. The company cited strong and steady demand for its kidney dialysis services and operational execution as key drivers for the improved financial performance and outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | DaVita HealthCare Partners Soars 7.10% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | DaVita HealthCare Partners Soars 7.10% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-06 16:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DaVita HealthCare Partners' stock surged 7.10% in pre-market trading on Wednesday, following the release of its first-quarter financial results for fiscal year 2026.</p><p>The significant pre-market gain was driven by the company reporting quarterly adjusted earnings that significantly exceeded Wall Street expectations. DaVita posted adjusted earnings per share of $2.87 for the quarter ended March 31, beating the analyst consensus estimate of $2.32. Revenue for the quarter climbed to $3.42 billion, also surpassing the market expectation of $3.36 billion.</p><p>Furthermore, DaVita raised its full-year 2026 adjusted earnings per share guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00. The company cited strong and steady demand for its kidney dialysis services and operational execution as key drivers for the improved financial performance and outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"","article_id":"1174231010","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174231010","pubTimestamp":1778057528,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"DaVita HealthCare Partners' stock surged 7.10% in pre-market trading on Wednesday, following the release of its first-quarter financial results for fiscal year 2026.The significant pre-market gain...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健"},"translate_title":"个股追踪|DaVita HealthCare Partners盘前飙升7.10%，因第一季度盈利强劲，并上调全年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":1},"content_text":"DaVita HealthCare Partners' stock surged 7.10% in pre-market trading on Wednesday, following the release of its first-quarter financial results for fiscal year 2026.The significant pre-market gain was driven by the company reporting quarterly adjusted earnings that significantly exceeded Wall Street expectations. DaVita posted adjusted earnings per share of $2.87 for the quarter ended March 31, beating the analyst consensus estimate of $2.32. Revenue for the quarter climbed to $3.42 billion, also surpassing the market expectation of $3.36 billion.Furthermore, DaVita raised its full-year 2026 adjusted earnings per share guidance to a range of $14.10 to $15.20, up from its previous outlook of $13.60 to $15.00. The company cited strong and steady demand for its kidney dialysis services and operational execution as key drivers for the improved financial performance and outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}